These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 6509251)

  • 21. Anti-leprosy vaccines--field trials and future prospects.
    Deo MG
    Indian J Lepr; 1984; 56(4):764-75. PubMed ID: 6442720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Under-explored experimental topics related to integral mycobacterial vaccines for leprosy.
    Gormus BJ; Meyers WM
    Expert Rev Vaccines; 2003 Dec; 2(6):791-804. PubMed ID: 14711362
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tuberculosis prevention: where do we go from here?
    Warndorff DK
    Afr Health; 1996 Nov; 19(1):21-2. PubMed ID: 12291917
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Regional lymphadenitis following antileprosy vaccine BCG with killed Mycobacterium leprae.
    De Britto RL; Ramanathan VD; Gupte MD
    Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):12-9. PubMed ID: 9207749
    [TBL] [Abstract][Full Text] [Related]  

  • 27. BCG vaccination in leprosy.
    Price JE
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):205-12. PubMed ID: 6749707
    [No Abstract]   [Full Text] [Related]  

  • 28. Immunosuppression and cellular immunity reactions in leprosy patients treated with a mixture of Mycobacterium leprae and BCG.
    Rada EM; Convit J; Ulrich M; Gallinotto ME; Aranzazu N
    Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):646-50. PubMed ID: 2963084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
    Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
    Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adoptive cell transfer of resistance to Mycobacterium leprae infections in mice.
    Lowe C; Brett SJ; Rees RJ
    Clin Exp Immunol; 1985 Aug; 61(2):336-42. PubMed ID: 3876183
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sensitization studies with potential leprosy vaccine preparations in northern Malawi.
    Ponnighaus JM; Fine PE
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):25-37. PubMed ID: 3519803
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Humoral and cellular immune reactivity to recombinant M. leprae antigens in HLA-typed leprosy patients and healthy controls.
    Klatser PR; Janson AM; Thole JE; Buhrer S; Bos C; Soebono H; de Vries RR
    Int J Lepr Other Mycobact Dis; 1997 Jun; 65(2):178-89. PubMed ID: 9251589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antileprosy protective vaccination of rhesus monkeys with BCG or BCG plus heat-killed Mycobacterium leprae: immunologic observations.
    Gormus BJ; Baskin GB; Xu K; Ratterree MS; Martin LN; Mack PA; Bohm RP; Meyers WM; Walsh GP
    Int J Lepr Other Mycobact Dis; 2000 Mar; 68(1):27-39. PubMed ID: 10834067
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A longitudinal study of immunologic reactivity in leprosy patients treated with immunotherapy.
    Rada E; Ulrich M; Aranzazu N; Santaella C; Gallinoto M; Centeno M; Rodriguez V; Convit J
    Int J Lepr Other Mycobact Dis; 1994 Dec; 62(4):552-8. PubMed ID: 7868953
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of the efficacy of candidate vaccines against M. leprae infection in mice.
    Sreevatsa ; Desikan KV
    Indian J Lepr; 1988 Apr; 60(2):252-9. PubMed ID: 3192974
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of delayed-type hypersensitivity by ICRC anti-leprosy vaccine and the adoptive transfer of cell-mediated immunity in mice.
    Jeevan A; Bapat CV
    Indian J Lepr; 1984; 56(4):754-63. PubMed ID: 6398339
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Leprosy.
    Meyers WM
    Dermatol Clin; 1992 Jan; 10(1):73-96. PubMed ID: 1730174
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Variable lepromin response to Mycobacterium leprae in resistant armadillos.
    Job CK; Kirchheimer WF; Sanchez RM
    Int J Lepr Other Mycobact Dis; 1983 Sep; 51(3):347-53. PubMed ID: 6685696
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tissue response to lepromin, an index of susceptibility of the armadillo to M. leprae infection--a preliminary report.
    Job CK; Kirchheimer WF; Sanchez RM
    Int J Lepr Other Mycobact Dis; 1982 Jun; 50(2):177-82. PubMed ID: 6749706
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.